Enzon Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 22   

Articles published

ENZN 0.975 +0.006 (0.61%)
price chart
Trending Stocks: Kindred Biosciences, Inc. (NASDAQ:KIN), Enzon ...
On last trading day Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) moved down -3.57% to close at $1.08. Its volatility for the week is 5.40% while volatility for the month is 8.15%.
Stocks in Focus - Enzon Pharmaceuticals Inc (ENZN), Spherix Inc (SPEX ...
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) reported a drop of -14.29%, after opening at the price of $1.25. Its closing price for the day was $1.08.
Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes ...
On Friday, shares in Enzon Pharmaceuticals Inc. fluctuated between $1.08 and $1.29 before ending the session 14.29% lower at $1.08.
Related articles »  
News Buzz � Convergys, (NYSE:CVG),Enzon Pharmaceuticals, (NASDAQ ...
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) With the latest decline of -9.09%, now has YTD performance 13.04% which for the week is negative at -23.53%.
Sigma-Tau, Alfa Wassermann in talks to combine Italian operations- sources
Sigma-Tau would retain control of its rare diseases business as well as its U.S. subsidiary, Sigma-Tau Pharmaceuticals Inc, which could then be sold separately in a deal worth over 1 billion euros ($1.28 billion), two of the sources said.
Related articles »  
Penny Stock Movers -Provectus Biopharmaceuticals, Inc. (PVCT), Great Panther ...
Provectus Biopharmaceuticals, Inc. (NYSEMKT:PVCT)declared thatSmall Cap Street continues coverage of PVCT. Melanoma that occurs on the skin, or cutaneous melanoma, is the most common type of melanoma.
Related articles »  
Trader's Watch List : Annaly Capital Management, Inc. (NYSE:NLY), ARMOUR ...
Mitcham Industries Inc. (NASDAQ:MIND) monthly performance is -16.03%. Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) has 4.95% insider ownership while its institutional ownership stands at 59.80%.
Related articles »  
Hot Alert: Aastrom Biosciences, Inc. (NASDAQ:ASTM), Facebook Inc (NASDAQ ...
Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) shares moved down -0.59% in last trading session and ended the day on $1.69. ENZN its return on assets is 158.00%.
Bankruptcy Filing Fallout Continues for NII Holdings
Corinthian Colleges Inc (NASDAQ:COCO), Rock Creek Pharmaceuticals Inc (NASDAQ:RCPI) and dELiA*s, Inc. (NASDAQ:DLIA) are today's top-gaining stocks.
Related articles »  
Cornerstone Pharmaceuticals Appoints Steve Carchedi Chief Executive Officer
CRANBURY, N.J., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced the appointment of Steve Carchedi as Chief ...
Related articles »